Synapse - Patrick Morris

Results (116)

Cardiac monitoring during clinical trials

Book Section

Morris, P. G.; Norton, L.
In Ewer, M. S.; Yeh, E. T. H. (Eds.) Cancer and the Heart. 2nd ed (2013)

Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)

Meeting Abstract

Iyengar, N. M.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R. J.; Steingart, R.; Oeffinger, K. C.; Lin, N. U.; Moy, B.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

How can we optimize modern imaging techniques for breast cancer, with main reference to breast recurrence?

Journal Article

Evangelista, L.; Morris, P. G.; Mansi, L.
Quarterly Journal of Nuclear Medicine and Molecular Imaging (2013)

Fulltext@MSK | Save

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome

Journal Article

Morris, P. G.; Correa, D. D.; Yahalom, J.; Raizer, J. J.; Schiff, D.; Grant, B.; Grimm, S.; Lai, R. K.; Reiner, A. S.; Panageas, K.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

The future of imaging for breast cancer recurrence

Journal Article

Mansi, L.; Evangelista, L.; Morris, P. G.
Quarterly Journal of Nuclear Medicine and Molecular Imaging (2013)

Fulltext@MSK | Save

How can we optimize modem imaging techniques for breast cancer, with main reference to breast recurrence?

Journal Article

Evangelista, L.; Morris, P. G.; Mansi, L.
Quarterly Journal of Nuclear Medicine and Molecular Imaging (2013)

Fulltext@MSK | Save

Biological subtypes of breast cancer: Current concepts and implications for recurrence patterns

Journal Article

Cadoo, K. A.; Fornier, M. N.; Morris, P. G.
Quarterly Journal of Nuclear Medicine and Molecular Imaging (2013)

Fulltext@MSK | Save

Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer